Seqirus

Overview

Seqirus: Revolutionizing Influenza Prevention and Control

Seqirus, the result of a groundbreaking merger between bioCSL and Novartis' influenza vaccine divisions in 2015, has quickly risen to become the second largest influenza vaccine company in the world. With a global presence and a rich heritage in influenza research and production, Seqirus is at the forefront of pandemic preparedness and the prevention and control of influenza on a global scale.

The parent company of Seqirus, CSL Limited, boasts a long-established history in influenza research, dating back to the devastating Spanish flu pandemic. The company's manufacturing facility in Melbourne, Australia, has been producing flu vaccines for nearly five decades, solidifying its position as a leader in the field. Seqirus Liverpool, located in the UK, serves as a Centre of Excellence for egg-based influenza vaccine manufacturing and is one of the largest biotechnology sites in Europe. It is also the sole injectable influenza vaccine manufacturer in the UK and produces the only licensed adjuvanted seasonal influenza vaccine.

One of the key strengths of Seqirus lies in its state-of-the-art vaccine production facility at the Holly Springs site in the US. This facility utilizes a novel cell culture-based process, providing an alternative to traditional egg-based influenza vaccine production. This innovative approach not only ensures a more efficient and reliable production process but also grants Seqirus vital additional capacity, particularly in the event of a pandemic.

With a workforce of over 2,000 employees and a commercial presence in twenty countries, Seqirus is a global powerhouse in the influenza vaccine industry. The merger between bioCSL and Novartis' influenza vaccine divisions has not only resulted in significant manufacturing capacity but also in product and geographic diversity. This diversity allows Seqirus to cater to the unique needs and demands of different regions, ensuring that communities around the world have access to the most effective influenza vaccines.

Working at Seqirus is an exciting prospect for employees who are passionate about making a difference in the field of public health. The company's commitment to pandemic preparedness and the prevention and control of influenza provides employees with a sense of purpose and fulfillment. Seqirus' extensive research and production expertise, coupled with its global presence, offers employees the opportunity to collaborate with leading experts in the field and contribute to cutting-edge advancements in influenza prevention and control.

Furthermore, Seqirus' transcontinental operations and diverse product portfolio provide employees with a unique and enriching work experience. The company's presence in multiple countries allows employees to gain exposure to different cultures and work environments, fostering a global mindset and promoting personal and professional growth. Additionally, Seqirus' diverse product range ensures that employees are constantly challenged and engaged, as they work on developing and manufacturing a wide variety of influenza vaccines to meet the specific needs of different populations.

Seqirus recognizes the importance of its employees and invests in their development and well-being. The company offers a range of training and development programs to enhance employees' skills and knowledge, ensuring that they stay at the forefront of the industry. Seqirus also prioritizes employee well-being, providing a supportive and inclusive work environment that promotes work-life balance and encourages a healthy lifestyle.

In conclusion, Seqirus is a dynamic and innovative company that is revolutionizing the field of influenza prevention and control. With its global presence, extensive research and production expertise, and diverse product portfolio, Seqirus offers employees an exciting and fulfilling work experience. The company's commitment to pandemic preparedness and its rich heritage in influenza research make Seqirus an ideal workplace for individuals who are passionate about making a difference in public health.